Anti-Hu TCR Cbeta1 PE

*Huppa JB, Ploegh HL: In vitro translation and assembly of a complete T cell receptor-CD3 complex. J Exp Med. 1997 Aug 4;186 (3) :393-403. , URL: https://www.ncbi.nlm.nih.gov/pubmed/9236191, *Viney JL, Prosser HM, Hewitt CR, Lamb JR, Owen MJ: Generation of monoclonal antibodies against a human T cell receptor beta chain expressed in transgenic mice. Hybridoma. 1992 Dec;11 (6) :701-13. , URL: https://www.ncbi.nlm.nih.gov/pubmed/1284120, *San José E, Alarcón B: Receptor engagement transiently diverts the T cell receptor heterodimer from a constitutive degradation pathway. J Biol Chem. 1999 Nov 19;274 (47) :33740-6., URL: https://pubmed.ncbi.nlm.nih.gov/10559266/, *Pasare C, Mukherjee P, Verhoef A, Bansal P, Mendiratta SK, George A, Lamb JR, Rath S, Bal V: T cells in mice expressing a transgenic human TCR beta chain get positively selected but cannot be activated in the periphery by signaling through TCR. Int Immunol. 2001 Jan;13 (1) :53-62., URL: https://pubmed.ncbi.nlm.nih.gov/11133834/, *Martin EP, Arnaud J, Alibaud L, Gouaillard C, Llobera R, Huchenq-Champagne A, Rubin B: Molecular mechanisms in the TCR (TCR alpha beta-CD3 delta epsilon, gamma epsilon) interaction with zeta 2 homodimers: clues from a 'phenotypic revertant' clone. Int Immunol. 1999 Jul;11 (7) :1005-15., URL: https://pubmed.ncbi.nlm.nih.gov/10383932/, *Horna P, Shi M, Olteanu H, Johansson U: Emerging role of T-cell receptor constant β chain-1 (TRBC1) expression in the flow cytometric diagnosis of T-cell malignancies. Int J Mol Sci. 2021 Feb 12;22 (4) :1817., URL: https://pubmed.ncbi.nlm.nih.gov/33673033/